Evidence map›Paper›PMID 39184339›Full record

ArticleFrontiers in digital health2024

On the design and development of a handheld electrocardiogram device in a clinical setting.

Alejandra Zepeda-Echavarria, Niek C M Ratering Arntz, Albert H Westra, Leonard J van Schelven, Froukje E Euwe, Herke Jan Noordmans, Melle Vessies, Rutger R van de Leur, Rutger J Hassink, Thierry X Wildbergh and 4 more

Abstract read
In one paragraph

Article in Frontiers in digital health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Holter features to detect coronary artery spasm in ANOCA patients: A pilot study.International journal of cardiology. Heart & vasculature · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alejandra Zepeda-EchavarriaDepartment of Medical Technology and Clinical Physics, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Niek C M Ratering ArntzDepartment of Medical Technology and Clinical Physics, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Albert H WestraDepartment of Medical Technology and Clinical Physics, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Leonard J van SchelvenDepartment of Medical Technology and Clinical Physics, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Froukje E EuweDepartment of Medical Technology and Clinical Physics, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Herke Jan NoordmansDepartment of Medical Technology and Clinical Physics, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Melle VessiesDepartment of Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Rutger R van de LeurDepartment of Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Rutger J HassinkDepartment of Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Thierry X WildberghDepartment of Cardiology, Meander Medical Center, Amersfoort, Netherlands.
Rien van der ZeeStichting Cardiovascular Biologie, Delft, Netherlands.
Pieter A DoevendansDepartment of Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
René van EsDepartment of Cardiology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Joris E N JaspersDepartment of Medical Technology and Clinical Physics, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases (CVDs) are a global burden that requires attention. For the detection and diagnosis of CVDs, the 12-lead ECG is a key tool. With technological advancements, ECG devices are becoming smaller and available for home use. Most of these devices contain a limited number of leads and are aimed to detect atrial fibrillation (AF). To investigate whether a four-electrode arrangement could provide enough information to diagnose other CVDs, further research is necessary. At the University Medical Center Utrecht in a multidisciplinary team, we developed the miniECG, a four-electrode ECG handheld system for scientific research in clinical environments (TRL6). This paper describes the process followed during the development of the miniECG. From assembling a multidisciplinary team, which includes engineers, cardiologists, and clinical physicians to the contribution of team members in the design input, design, and testing for safety and functionality of the device. Finally, we detail how the development process was composed by iterative design steps based on user input and intended use evolution. The miniECG is a device compliant for scientific research with patients within Dutch Medical Centers. We believe that hospital-based development led to a streamlined process, which could be applied for the design and development of other technologies used for scientific research in clinical environments.

Indexed as

clinical scientific researchdesign and development, TRLmobile ECGwearables

Identifiers

PMID39184339
PMCPMC11341539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.